These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8242611)
1. Expression of the tumor suppressor gene DCC in human gliomas. Scheck AC; Coons SW Cancer Res; 1993 Dec; 53(23):5605-9. PubMed ID: 8242611 [TBL] [Abstract][Full Text] [Related]
2. Loss of DCC expression and glioma progression. Reyes-Mugica M; Rieger-Christ K; Ohgaki H; Ekstrand BC; Helie M; Kleinman G; Yahanda A; Fearon ER; Kleihues P; Reale MA Cancer Res; 1997 Feb; 57(3):382-6. PubMed ID: 9012460 [TBL] [Abstract][Full Text] [Related]
3. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the DCC tumor suppressor gene in testicular germ cell tumors: mutations and loss of expression. Strohmeyer D; Langenhof S; Ackermann R; Hartmann M; Strohmeyer T; Schmidt B J Urol; 1997 May; 157(5):1973-6. PubMed ID: 9112574 [TBL] [Abstract][Full Text] [Related]
6. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Chernova OB; Somerville RP; Cowell JK Oncogene; 1998 Dec; 17(22):2873-81. PubMed ID: 9879993 [TBL] [Abstract][Full Text] [Related]
7. DCC expression is altered by multiple mechanisms in brain tumours. Ekstrand BC; Mansfield TA; Bigner SH; Fearon ER Oncogene; 1995 Dec; 11(11):2393-402. PubMed ID: 8570191 [TBL] [Abstract][Full Text] [Related]
8. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Gao X; Honn KV; Grignon D; Sakr W; Chen YQ Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of a novel human brain tumor-associated gene BR-3. Weil KC; Berge MS; Sehgal A Anticancer Res; 2002; 22(3):1467-74. PubMed ID: 12168825 [TBL] [Abstract][Full Text] [Related]
10. Expression of the genes encoding myelin basic protein and proteolipid protein in human malignant gliomas. Golfinos JG; Norman SA; Coons SW; Norman RA; Ballecer C; Scheck AC Clin Cancer Res; 1997 May; 3(5):799-804. PubMed ID: 9815752 [TBL] [Abstract][Full Text] [Related]
11. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of a novel BR-2 gene that is down-regulated in human low grade glioma tumors. Wei KC; Berger MS; Sehgal A Anticancer Res; 2002; 22(2A):649-57. PubMed ID: 12014633 [TBL] [Abstract][Full Text] [Related]
14. Cloning, sequencing and expression analysis of a novel gene BR-1 that is expressed in normal human brain tissue but not in glioma tumor samples. Wei KC; Berger MS; Sehgal A Anticancer Res; 2002; 22(2A):745-53. PubMed ID: 12014646 [TBL] [Abstract][Full Text] [Related]
15. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120 [TBL] [Abstract][Full Text] [Related]
16. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786 [TBL] [Abstract][Full Text] [Related]
17. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL; J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268 [TBL] [Abstract][Full Text] [Related]
18. Molecular pathways in the formation of gliomas. von Deimling A; Louis DN; Wiestler OD Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467 [TBL] [Abstract][Full Text] [Related]
19. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Liau LM; Lallone RL; Seitz RS; Buznikov A; Gregg JP; Kornblum HI; Nelson SF; Bronstein JM Cancer Res; 2000 Mar; 60(5):1353-60. PubMed ID: 10728698 [TBL] [Abstract][Full Text] [Related]
20. A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus. Ichimura K; Schmidt EE; Yamaguchi N; James CD; Collins VP Cancer Res; 1994 Jun; 54(12):3127-30. PubMed ID: 8205529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]